Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/44780
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGrimaldi, M.-
dc.contributor.authorPhlips, T.-
dc.contributor.authorDe Potter, T.-
dc.contributor.authorRosso, R.-
dc.contributor.authorNg, G. A.-
dc.contributor.authorDuytschaever, M.-
dc.contributor.authorSarkozy, A.-
dc.contributor.authorLambiase, P. D.-
dc.contributor.authorDeneke, T.-
dc.contributor.authorDeisenhofer, I-
dc.contributor.authorQuadrini, F.-
dc.contributor.authorVIJGEN, Johan-
dc.contributor.authorPurerfellner, H.-
dc.date.accessioned2024-12-09T07:05:58Z-
dc.date.available2024-12-09T07:05:58Z-
dc.date.issued2024-
dc.date.submitted2024-12-06T14:48:41Z-
dc.identifier.citationEuropean heart journal, 45 (S1) (Art N° ehae666553)-
dc.identifier.urihttp://hdl.handle.net/1942/44780-
dc.description.sponsorshipType of funding sources: Private company. Main funding source(s): Biosense Webster, Inc.-
dc.language.isoen-
dc.publisherOXFORD UNIV PRESS-
dc.titleAtrial fibrillation ablation with temperature-controlled very high-power short-duration, with conventional-power, or with combined modes in clinical practice: 12-month outcomes from SECURE-
dc.typeJournal Contribution-
dc.identifier.issueS1-
dc.identifier.volume45-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notesfiatric@hotmail.com; Thomas.Phlips@jessazh.be;-
dc.description.notestom.de.potter@olvz-aalst.be; roswin1@gmail.com;-
dc.description.notesandre.ng@leicester.ac.uk; mattias.duytschaever@azsintjan.be;-
dc.description.notesandreasarkozy@yahoo.ca; p.lambiase@nhs.net; Thomas.Deneke@campus-nes.de;-
dc.description.notesdeisenhofer@dhm.mhn.de; federico.quadrini@tin.it;-
dc.description.notesjohan.vijgen@jessazh.be; Helmut.Puererfellner@ordensklinikum.at-
local.publisher.placeGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrehae666553-
dc.identifier.doi10.1093/eurheartj/ehae666.553-
dc.identifier.isi001365056700037-
local.provider.typewosris-
local.description.affiliation[Grimaldi, M.; Quadrini, F.] Osped Gen Regionale F Miulli, Bari, Italy.-
local.description.affiliation[Phlips, T.; Vijgen, J.] Virga Jessa Ziekenhuis, Hasselt, Belgium.-
local.description.affiliation[De Potter, T.] Onze Lieve Vrouw Hosp, Aalst, Belgium.-
local.description.affiliation[Rosso, R.] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel.-
local.description.affiliation[Ng, G. A.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester, England.-
local.description.affiliation[Duytschaever, M.] Acad Hosp St Jan, Brugge, Belgium.-
local.description.affiliation[Sarkozy, A.] Univ Ziekenhuis Antwerpen, Antwerp, Belgium.-
local.description.affiliation[Lambiase, P. D.] UCL, London WC2R 2LS, England.-
local.description.affiliation[Lambiase, P. D.] Barts Heart Ctr, London, England.-
local.description.affiliation[Deneke, T.] RHON KLINIKUM, Campus Bad Neustadt, Bad Neustadt an der Saale, Germany.-
local.description.affiliation[Deisenhofer, I] German Heart Ctr Munich, Munich, Germany.-
local.description.affiliation[Deisenhofer, I] Tech Univ Munich TUM, Munich, Germany.-
local.description.affiliation[Purerfellner, H.] Ordensklinikum Linz Elisabethinen, Linz, Austria.-
local.uhasselt.internationalyes-
item.fulltextWith Fulltext-
item.contributorGrimaldi, M.-
item.contributorPhlips, T.-
item.contributorDe Potter, T.-
item.contributorRosso, R.-
item.contributorNg, G. A.-
item.contributorDuytschaever, M.-
item.contributorSarkozy, A.-
item.contributorLambiase, P. D.-
item.contributorDeneke, T.-
item.contributorDeisenhofer, I-
item.contributorQuadrini, F.-
item.contributorVIJGEN, Johan-
item.contributorPurerfellner, H.-
item.fullcitationGrimaldi, M.; Phlips, T.; De Potter, T.; Rosso, R.; Ng, G. A.; Duytschaever, M.; Sarkozy, A.; Lambiase, P. D.; Deneke, T.; Deisenhofer, I; Quadrini, F.; VIJGEN, Johan & Purerfellner, H. (2024) Atrial fibrillation ablation with temperature-controlled very high-power short-duration, with conventional-power, or with combined modes in clinical practice: 12-month outcomes from SECURE. In: European heart journal, 45 (S1) (Art N° ehae666553).-
item.accessRightsOpen Access-
crisitem.journal.issn0195-668X-
crisitem.journal.eissn1522-9645-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
ehae666-2 226..227.pdfPublished version211.79 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.